Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Result of incentive program in Initiator Pharma A/S

PRESS RELEASE 1 October 2021 The AGM held on May 28, 2021 approved a long-term incentive program (“LTI2021”) for key personnel and board members. Under this program the board is authorized to allow participants in the program to acquire up to 220.000 ordinary shares in the market at market price (“Investment Shares”) until September 30, 2021, with each Investment Share carrying the right to subscribe for 1 new share at par value at the next AGM providing that the individual owning the Investment Share is still with the company at the time (“Matching Share”). Each Investment Share

Bonava divests assets in Copenhagen

Bonava has signed an agreement to divest its remaining land bank in Copenhagen, Denmark, to Ikano Bolig A/S for a cash purchase price of SEK 545 million. The divestment will have a positive effect on pre-tax profit, including transaction costs, of SEK 226 million during the fourth quarter of 2021.On 25 May 2021, Bonava announced its decision to wind down its operations in Copenhagen to increase efficiency and profitability in the Group, as well as its plan to divest its remaining land bank during the second half of 2021. Bonava has now reached an agreement to divest its land bank in

The last day for trading in the warrants of series TO 4 in Idogen AB is today, October 1, 2021

Today, October 1, 2021, is the last day for trading in warrants of series TO 4 in Idogen AB. The subscription period for the warrants of series TO 4 runs until October 5, 2021. Each warrant of series TO 4 gives the right to subscribe for one (1) new share in Idogen. The subscription price for the TO 4 warrants is SEK 2.06 per share. If all warrants of series TO 4 are exercised, Idogen will receive approximately MSEK 18 before issue costs. In order for the warrants not to lapse without value, the holder must actively subscribe for shares no later than October 5, 2021, or alternatively

BioStock: Respiratorius gets patent approval in Brazil for VAL001

Barely a month ago, Respiratorius received a patent approval in the EU for its RESP9000 series of drug candidates. Now it is announcing further patent news in the form of an approval in Brazil, this time for the drug candidate VAL001. With this approval, the candidate will be given market exclusivity in Brazil until 2031.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/respiratorius-gets-patent-approval-in-brazil-for-val001/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Mirovia acquires Traventus, thus investing further in the ERP sector

1 October 2021 Today Mirovia Group entered an agreement to acquire the business consultants Traventus AB, thereby further strengthening its business within ERP. The collaboration with Traventus will begin in the autumn of 2021. Traventus was founded in 2012 and is one of Sweden's leading specialists in Visma's ERP systems. They offer comprehensive solutions for the ERP systems Visma Business, Visma.net ERP and Visma SPCS with a total of 30 employees. In 2020, Traventus turnover amounted to SEK 27.8 million with an EBITDA of SEK 6.7 million, of which almost 40% were income of a

U.S. court issues decision in Trintellix patent litigation upholding active ingredient patent

Valby, Denmark, 1 October 2021 - H. Lundbeck A/S (Lundbeck) announces that the U.S. District Court for the District of Delaware (the ‘Court’) has issued its decision upholding the validity of Lundbeck’s patent covering the active ingredient in Trintellix, vortioxetine (U.S. Patent No. 7,144,884) in patent litigation proceedings against six generic manufacturers challenging Lundbeck’s patent rights to Trintellix (vortioxetine) in the U.S. Lundbeck and its partner, Takeda Pharmaceutical Company Limited (Takeda), filed the infringement actions against the six generic manufacturers Alembic,

Invitation to Epiroc’s results presentation for Q3 2021 on October 21

Stockholm, Sweden: Epiroc AB, a leading productivity and sustainability partner for the mining and infrastructure industries, will publish its Q3 2021 results on Thursday October 21 at approximately 07.30 am CEST. A results presentation for investors, analysts and media will be held at 10.00 am CEST.The report will be presented by President and CEO Helena Hedblom and CFO Anders Lindén. It will be held in English and begin with a short presentation of the report followed by a question-and-answer session. To join the presentation, either access the link here 

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 30th September 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 25,872,967 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Gaming Innovation Group expands with two new platform agreements with existing partner

Gaming Innovation Group Inc. (GiG) has signed two long-term agreements with an existing partner for the provision of GiG’s iGaming platform (Core) technologies to facilitate the operator’s multi-brand strategy and expansion into a number of EU markets. The contract has a fixed fee structure with a minimum duration of four years.Richard Brown, Chief Executive Officer of GiG says: “It is always a proud moment when an existing partner decides to expand the collaboration with additional brands and contracts, showing the value and power of our platform and its’ services. We are very much

Warrants of series TO1 were subscribed to approximately 96.9 percent and Cereno Scientific AB (publ) receives approximately SEK 95.3 million.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Cereno Scientific AB (publ) (“Cereno” or the “Company”) announces today the outcome of the exercise of warrants of series TO1, which were issued during the fourth quarter of 2020.

Global agreement on indoor mapping for LinkedIn

MapsPeople A/S | Global agreement on indoor mapping for LinkedIn MAY NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR IN PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, CANADA, OR JAPAN. This announcement does not constitute an offering circular, Prospectus, or other offer document. No one should purchase or subscribe for any securities in MapsPeople A/S ("MapsPeople" or the "Company") except on the basis of information in the Prospectus published by the Company in connection with the Offering and admission of such securities to trading on Nasdaq First North Premier Growth

Smoltek publishes update on the operational activities in the group company Smoltek Innovation

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the group company Smoltek Innovation's efforts to develop a unique and high-performance nanofiber-based cell material for electrolyzers used in fossil-free hydrogen production continues to develop according to plan. Dialogues are now ongoing with the aim of signing a collaboration agreement with a major manufacturer for the continued development of the concept.“We are noticing a strong interest in our unique cell

Amendment of disclosure policy of Tikkurila Oyj

The Board of Directors of Tikkurila Oyj (“Tikkurila” or the “Company”) has today resolved to amend the Company’s disclosure policy so that on a yearly basis the Company will publish only a financial statement release and a half-year report.The Company’s updated disclosure policy is available on its website. As a consequence of this amendment, the Company is also updating its financial reporting calendar, which was published on 28 August 2020, to reflect that the January-September 2021 business review will not be published. DISTRIBUTION Nasdaq Helsinki Ltd Main news media For

Capitainer Wins Swedish Guldpillret for its qDBS self-sampling device

“Smart” card ensures blood samples collected at home fully meet the standards required for sophisticated laboratory testing Stockholm, Sweden, October 1, 2021. Capitainer announced today that the company has received a prestigious Guldpillret (Golden Pill) award for its unique home blood sampling device. Established by Läkemedelsförsäkringen, the prize is awarded annually to highlight the need for better and safer use of medicines. Self-sampling with the Capitainer qDBS collection device has really come into own during the COVID-19 pandemic. It was deployed in northern Sweden to enable

Capitainer Wins Swedish Guldpillret for its qDBS self-sampling device

“Smart” card ensures blood samples collected at home fully meet the standards required for sophisticated laboratory testing Stockholm, Sweden, October 1, 2021. Capitainer announced today that the company has received a prestigious Guldpillret (Golden Pill) award for its unique home blood sampling device. Established by Läkemedelsförsäkringen, the prize is awarded annually to highlight the need for better and safer use of medicines. Self-sampling with the Capitainer qDBS collection device has really come into own during the COVID-19 pandemic. It was deployed in northern Sweden to enable

Archer Limited: Changes to the Board of Directors

Hamilton, Bermuda (October 1, 2021) Archer Limited announces today that the board of directors has appointed Jan Erik Klepsland as director.  Mr. Klepsland will replace Kristian Melhuus, who resign as director of the Archer board. The board would like to thank Mr. Melhuus for his substantial contribution to Archer over the past years. Jan Erik Klepsland is a Director of Seatankers Management Norway AS. He holds a MSc in Finance from Norwegian School of Economics (NHH). Prior to joining Seatankers, he held the position as Partner at ABG Sundal Collier and Director in Nordea. He has

AFRY is one of Sweden's most attractive employers

Companies with a clear focus on sustainability and society continue to attract young engineers who want to be involved and influence their future. AFRY is one of the companies that comes high on the list when both young and more experienced engineers get to rank their dream employers.Universum's latest survey, where engineers rank the most attractive employers in Sweden, shows that AFRY is strengthening its attractiveness among young professional civil engineers. In this year's survey, AFRY lands in third place when young professional college engineers rank dream employers and in eighth

Genetic Analysis AS (GEAN): First day of trading in Genetic Analysis shares and warrants on Spotlight Stock Market

OSLO, NORWAY - 1 October 2021: First day of trading in Genetic Analysis AS (“GA” or “the Company”) shares and warrants on Spotlight Stock Market (“Spotlight”) begins today. The Company's shares are traded under the short name “GEAN” and ISIN code NO0010692130 and warrants of series TO 1 are traded under the short name “GEAN TO 1” and ISIN code NO0011054223. Warrants of series TO 2 are traded under the short name “GEAN TO 2” and ISIN code NO0011054231.CEO Ronny Hermansen comments«The listing of GA is a major milestone in our mission to become the world leading company within microbiome

Metso Outotec awarded EUR 100 million contract for the delivery of a nickel-copper concentrator in Russia

Metso Outotec Corporation’s press release on October 1, 2021, at 09:00 a.m. EESTMetso Outotec has signed a landmark contract to deliver all key technology for a new concentrator plant in Norilsk, Russia. The concentrator is operated by Chernogorskaya mining company, which is part of the Russian Platinum group. The delivery is based on Metso Outotec’s proprietary technology and includes key equipment for grinding, flotation and separation. Metso Outotec will also deliver electrification, instrumentation and automation for the concentrator. The contract exceeding EUR 100 million has been

NOTICE OF GENERAL MEETING

H & M Hennes & Mauritz AB (publ) (556042-7220) will hold an extraordinary general meetingon 28 October 2021.In view of the risk of spreading coronavirus, the board of directors has decided to hold the meeting in such a way that participants take part only by postal voting in accordance with § 22 of the Swedish Act (2020:198) on temporary exemptions to facilitate the holding of general meetings of companies and associations. Shareholders can only exercise their voting rights at the meeting by submitting a postal vote in accordance with the instructions below. Right to participate and

Results of Placing and Issue Price

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE EU REGULATION 596/2014 ("MAR") AND ARTICLE 7 OF MAR AS INCORPORATED INTO UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL)

Solteq Plc's CEO Leaves His Position in January 2022

Stock Exhange Bulletin October 1, 2021 at 9:00 a.m. CEO of Solteq Plc, Olli Väätäinen, has announced his resignation in order to assume a new position outside of Solteq. Väätäinen will continue in his current position as CEO of Solteq until the end of January 2022. The company will immediately start a process for finding a new CEO.  “I wish to thank Olli Väätäinen on behalf of the Board and the entire company for his significant contribution to the development of the company and leading towards profitable growth both domestically and internationally. I wish him success in the new

Nordea’s Board of Directors has decided on distribution of ordinary dividend

Nordea Bank AbpStock exchange release – Other information disclosed according to the rules of the Exchange 1 October 2021 at 09.00 EET  The Board of Directors of Nordea has today decided to distribute an ordinary dividend of EUR 0.72 per share to shareholders in accordance with the mandate received from the Annual General Meeting (“AGM”) in 2021. The ordinary dividend of EUR 0.72 per share will be paid to shareholders who on the record date for the dividend payment on 5 October 2021 are recorded in Nordea’s shareholders’ register maintained by Euroclear Finland Oy in Finland,

There are no items matching the current filter
There are no more items matching the current filter
Back to top